Sign In
Buy GTLL
$0.0002
+0 (+0%)
At Close: Jun 05, 2026
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
08:00am, Thursday, 29'th May 2025
PHILADELPHIA, May 29, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies
CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
08:00am, Thursday, 29'th May 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that Sean Mc
Peloton Announces Participation in the Bank of America Global Technology Conference
04:49pm, Wednesday, 28'th May 2025
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (Nasdaq: PTON) announced its Chief Executive Officer and President, Peter Stern, will participate in a fireside chat at the Bank of
SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025
04:30pm, Wednesday, 28'th May 2025
SANTA CLARA, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be partic
Winnebago Industries to Participate in Fireside Chat at Baird's 2025 Global Consumer, Technology & Services Conference
04:30pm, Wednesday, 28'th May 2025
EDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE: WGO), a leading manufacturer of outdoor recreation products, today announced that President and Chief Executive
Global Payments Divests Payroll Unit to Acrisure for $1.1 Billion
04:12pm, Wednesday, 28'th May 2025
Payment tech company Global Payments is selling its payroll business for $1.1 billion. Global Payments will divest payroll operations to Michigan-based FinTech Acrisure, according to a Wednesday (May
Global Medical REIT Inc. Board Declares 2025 Second Quarter Common and Preferred Dividends
04:07pm, Wednesday, 28'th May 2025
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. Board Declares 2025 Second Quarter Common and Preferred Dividends.
Vir Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
04:05pm, Wednesday, 28'th May 2025
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will participate in a fireside chat at the G
Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
04:05pm, Wednesday, 28'th May 2025
SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune syste
Supernus to Participate in the 2025 Jefferies Global Healthcare Conference
04:05pm, Wednesday, 28'th May 2025
ROCKVILLE, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of cent
Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference
04:05pm, Wednesday, 28'th May 2025
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapi
Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
04:05pm, Wednesday, 28'th May 2025
FREMONT, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming G
Kyverna Therapeutics to Present at the Jefferies Global Healthcare Conference
04:02pm, Wednesday, 28'th May 2025
EMERYVILLE, Calif. , May 28, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with
Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference
04:01pm, Wednesday, 28'th May 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immun
Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
04:01pm, Wednesday, 28'th May 2025
SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership t
